1 reports of this reaction
2.2% of all ASPIRIN, CAFFEINE reports
#4 most reported adverse reaction
ANAPHYLACTOID REACTION is the #4 most commonly reported adverse reaction for ASPIRIN, CAFFEINE, manufactured by CVS Pharmacy. There are 1 FDA adverse event reports linking ASPIRIN, CAFFEINE to ANAPHYLACTOID REACTION. This represents approximately 2.2% of all 45 adverse event reports for this drug.
Patients taking ASPIRIN, CAFFEINE who experience anaphylactoid reaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAPHYLACTOID REACTION is a less commonly reported adverse event for ASPIRIN, CAFFEINE, but still significant enough to appear in the safety profile.
In addition to anaphylactoid reaction, the following adverse reactions have been reported for ASPIRIN, CAFFEINE:
ANAPHYLACTOID REACTION has been reported as an adverse event in 1 FDA reports for ASPIRIN, CAFFEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAPHYLACTOID REACTION accounts for approximately 2.2% of all adverse event reports for ASPIRIN, CAFFEINE, making it a notable side effect.
If you experience anaphylactoid reaction while taking ASPIRIN, CAFFEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.